<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        3010222846
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2022
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Syngro
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        OCTREOTIDE ACETATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intramuscular use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Powder and solvent for prolonged-release suspension for injection
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Vial
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store in a refrigerator (2°c – 8°c)
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        1510.30
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="PHARMATHEN INTERNATIONAL" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            PHARMATHEN INTERNATIONAL
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 441]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Jazeera Pharmaceutical Industries (JPI)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Jazeera Pharmaceutical Industries (JPI)	
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        QH01CB02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Syngro is a synthetic compound derived from somatostatin. Somatostatin is normally found in the human body, where it inhibits the release of certain hormones such as growth hormone. The advantages of Syngro over somatostatin are that it is stronger and its effects last longer.</p><p><strong>Syngro is used</strong></p><ul><li>To treat acromegaly.</li></ul><p>Acromegaly is a condition where the body produces too much growth hormone. Normally, growth hormone controls growth of tissues, organs, and bones. Too much growth hormone leads to an increase in the size of bones and tissues, especially in the hands and feet. Syngro markedly reduces the symptoms of acromegaly, which include headache, excessive perspiration, numbness of the hands and feet, tiredness, and joint pain. In most cases, the overproduction of growth hormone is caused by an enlargement in the pituitary gland (a pituitary adenoma); Syngro treatment may reduce the size of the adenoma.</p><p>Syngro is used to treat people with acromegaly:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; When other types of treatment for acromegaly (surgery or radiotherapy) are not suitable or haven&rsquo;t worked;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; After radiotherapy, to cover the interim period until the radiotherapy becomes fully effective.</p><ul><li>To relieve symptoms associated with overproduction of some specific hormones and other related substances by the stomach, bowels or pancreas.</li></ul><p>Overproduction of specific hormones and other related natural substances can be caused by some rare conditions of the stomach, bowels or pancreas. This upsets the natural hormonal balance of the body and results in a variety of symptoms, such as flushing, diarrhoea, low blood pressure, rash, and weight loss. Treatment with Syngro helps to control these symptoms.&nbsp;</p><ul><li>To treat neuroendocrine tumours located in the gut (e.g. appendix, small intestine or colon).</li></ul><p>Neuroendocrine tumours are rare tumours which can be found in different parts of the body.</p><p>Syngro is also used to control the growth of these tumours, when they are located in the gut (e.g. appendix, small intestine or colon).</p><ul><li>To treat pituitary tumours that produce too much thyroid-stimulating hormone (TSH).</li></ul><p>Too much thyroid-stimulating hormone (TSH) leads to hyperthyroidism. Syngro is used to treat people with pituitary tumours that produce too much thyroid-stimulating hormone (TSH):</p><p>-&nbsp; &nbsp; &nbsp;When other types of treatment (surgery or radiotherapy) are not suitable or have not worked;</p><p>-&nbsp; &nbsp; &nbsp;After radiotherapy, to cover the interim period until the radiotherapy becomes fully effective.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Follow all instructions given to you by your doctor carefully. They may differ from the information contained in this leaflet.</p><p>Read the following explanations before you use Syngro.</p><p><strong>Do not use Syngro </strong></p><ul><li>If you are allergic to octreotide or any of the other ingredients of this medicine (listed in section 6).</li></ul><p><strong>Warnings and precautions </strong></p><p>Talk to your doctor before using Syngro:</p><ul><li>If you know that you have gallstones now, or have had them in the past or experience any complications like fever, chills, abdominal pain, or yellowing of your skin or eyes; tell your doctor, as prolonged use of Syngro may result in gallstone formation. Your doctor may wish to check your gallbladder periodically.</li><li>If you know that you have diabetes, as Syngro can affect blood sugar levels. If you are diabetic, your sugar levels should be checked regularly.</li><li>If you have a history of vitamin B12 deprivation your doctor may wish to check your vitamin B12 level periodically.</li></ul><p><strong>Test and checks</strong></p><p>If you receive treatment with Syngro over a long period of time, your doctor may wish to check your thyroid function periodically.</p><p>Your doctor will check your liver function.</p><p><strong>Children </strong></p><p>There is little experience with the use of octreotide in children.</p><p><strong>Other medicines and </strong><strong>Syngro</strong></p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.</p><p>You can generally continue taking other medicines while on Syngro. However, certain medicines, such as cimetidine, ciclosporin, bromocriptine, quinidine and terfenadine have been reported to be affected by octreotide.</p><p>If you are taking a medicine to control your blood pressure (e.g. a beta blocker or a calcium channel blocker) or an agent to control fluid and electrolyte balance, your doctor may need to adjust the dosage.</p><p>If you are diabetic, your doctor may need to adjust your insulin dosage.</p><p><strong>Pregnancy and breast-feeding </strong></p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.</p><p>Syngro should only be used during pregnancy if clearly needed.</p><p>Women of child-bearing age should use an effective contraceptive method during treatment.</p><p>Do not breast-feed while using Syngro. It is not known whether octreotide passes into breast milk.</p><p><strong>Driving and using machines </strong></p><p>Syngro has no or negligible effects on the ability to drive and use machines. However, some of the side effects you may experience while using octreotide, such as headache and tiredness, may reduce your ability to drive and use machines safely.</p><p><strong>Syngro contains sodium</strong></p><p>Syngro contains sodium. This medicine contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially &lsquo;sodium-free&rsquo;.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Syngro must always be administered as an injection into the muscle of the buttocks. With repeated administration, the left and right buttock should be used alternately.</p><p><strong>If you use more Syngro than you should</strong></p><p>No life-threatening reactions have been reported after overdose of octreotide.</p><p>The symptoms of overdose are: hot flushes, frequent urination, tiredness, depression, anxiety and lack of concentration.</p><p>If you think that an overdose has happened and you experience such symptoms, tell your doctor straight away.</p><p><strong>If you forget to use Syngro</strong></p><p>If your injection is forgotten, it is recommended that you are given it as soon as it is remembered, and then continue as usual. It will not do any harm if a dose is a few days late, but you could get some temporary re-appearance of symptoms until you get back on schedule.</p><p><strong>If you stop using Syngro</strong></p><p>If you interrupt your treatment with Syngro your symptoms may come back. Therefore, do not stop using Syngro unless your doctor tells you to.</p><p>If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p><strong><em>Some side effects could be serious. Tell your doctor straight away if you get any of the following: </em></strong></p><p><strong>Very common (may affect more than 1 in 10 people): </strong></p><ul><li>Gallstones, causing sudden back pain.</li><li>Too much sugar in the blood.</li></ul><p><strong>Common</strong> <strong>(may affect up to 1 in 10 people):</strong></p><ul><li>Underactive thyroid gland (hypothyroidism) causing changes in heart rate, appetite or weight; tiredness, feeling cold, or swelling at the front of the neck.</li><li>Changes in thyroid function tests.</li><li>Inflammation of the gallbladder (cholecystitis); symptoms may include pain in the upper right abdomen, fever, nausea, yellowing of the skin and eyes (jaundice).</li><li>Too little sugar in the blood.</li><li>Impaired glucose tolerance.</li><li>Slow heart beat.</li></ul><p><strong>Uncommon</strong> <strong>(may affect up to 1 in 100 people): </strong></p><ul><li>Thirst, low urine output, dark urine, dry flushed skin.</li><li>Fast heart beat.</li></ul><p><strong><em>Other serious side effects</em></strong></p><ul><li>Hypersensitivity (allergic) reactions including skin rash.</li><li>A type of an allergic reaction (anaphylaxis) which can cause difficulty in swallowing or breathing, swelling and tingling, possibly with a drop in blood pressure with dizziness or loss of consciousness.</li><li>An inflammation of the pancreas gland (pancreatitis); symptoms may include sudden pain in the upper abdomen, nausea, vomiting, diarrhoea.</li><li>Liver inflammation (hepatitis); symptoms may include yellowing of the skin and eyes (jaundice), nausea, vomiting, loss of appetite, generally feeling unwell, itching, light-coloured urine.</li><li>Irregular heart beat.</li><li>Low level of platelet count in blood; this could result in increased bleeding or bruising.</li></ul><p>Tell your doctor straight away if you notice any of the side effects above.</p><p><strong><em>Other side effects:</em></strong></p><p>Tell your doctor, pharmacist or nurse if you notice any of the side effects listed below. They are usually mild and tend to disappear as treatment progresses.</p><p><strong>Very common</strong> <strong>(may affect more than 1 in 10 people):</strong></p><ul><li>Diarrhoea.</li><li>Abdominal pain.</li><li>Nausea.</li><li>Constipation.</li><li>Flatulence (wind).</li><li>Headache.</li><li>Local pain at the injection site.</li></ul><p><strong>Common (may affect up to 1 in 10 people):</strong></p><ul><li>Stomach discomfort after meal (dyspepsia).</li><li>Vomiting.</li><li>Feeling of fullness in the stomach.</li><li>Fatty stools.</li><li>Loose stools.</li><li>Discolouration of faeces.</li><li>Dizziness.</li><li>Loss of appetite.</li><li>Change in liver function tests.</li><li>Hair loss.</li><li>Shortness of breath.</li><li>Weakness.</li></ul><p>If you get any side effects, please tell your doctor, nurse or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p>Store in a refrigerator (2-8&deg;C). Do not freeze.</p><p>Store in the original package in order to protect from light.</p><p>Syngro may be stored below 25&deg;C on the day of injection.</p><p>After reconstitution, use immediately.</p><p>Do not use this medicine after the expiry date which is stated on the package after &ldquo;EXP&rdquo;. &nbsp;The expiry date refers to the last day of that month.</p><p>Do not use this medicine if you notice particles or a change of colour.</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is octreotide acetate.</p><p>Each vial of Syngro 10 mg Powder for Prolonged-release Suspension for Injection contains 11.2 mg octreotide acetate equivalent to 10 mg octreotide.</p><p>Each vial of Syngro 20 mg Powder for Prolonged-release Suspension for Injection contains 22.4 mg octreotide acetate equivalent to 20 mg octreotide.</p><p>Each vial of Syngro 30 mg Powder for Prolonged-release Suspension for Injection contains 33.6 mg octreotide acetate equivalent to 30 mg octreotide.</p><p>The other ingredients are:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; Powder (vial): Poly (DL-lactide-co-glycolide) and mannitol.</p><p>-&nbsp; &nbsp; &nbsp;Solvent (pre-filled syringe): Carmellose sodium, mannitol, poloxamer and water for injection.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Syngro 10 mg, 20 mg and 30 mg Powder and Solvent for Prolonged-release Suspension for Injection:
Powder: Is a white to off-white powder free from foreign particles in 8 ml type I, clear glass vials, stoppered with chlorobutyl rubber stoppers and sealed with aluminum flip-off caps of different colours (dark blue, orange and dark red flip-off caps are used for 10 mg, 20 mg and 30 mg; respectively). 

Solvent: Is a clear, colourless, aqueous solution free from foreign particles in 3 ml type I, clear glass pre-filled syringes with tip caps stoppered with a grey colour, bromobutyl plunger stoppers. A plunger rod is attached at the back end of the plunger stopper. 

The filled and sealed vial is placed in a plastic tray along with the pre-filled syringe, safety injection needle and vial adapter; all are packaged in cardboard box. 

Pack size: 1 Vial + 1 Pre-filled syringe (2 ml).
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorization Holder and Batch releaser </strong></p><p>Jazeera Pharmaceutical Industries<br />Al-Kharj Road<br />P.O. BOX 106229<br />Riyadh 11666, Saudi Arabia<br />Tel: + (966-11) 8107023, + (966-11) 2142472<br />Fax: + (966-11) 2078170<br />e-mail: SAPV@hikma.com</p><p><strong>Bulk manufacturer and Under licensed from</strong></p><p>Pharmathen International S.A</p><p>Industrial Park Sapes,</p><p>Rodopi Prefecture, Block No 5,</p><p>Rodopi 69300,</p><p>Greece</p><p>&nbsp;</p><p><strong>Reporting of side effects</strong></p><p>If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see details below). By reporting side effects, you can also help provide more information on the safety of this medicine.</p><ul><li>&nbsp; &nbsp; Saudi Arabia</li></ul><p>The National Pharmacovigilance Centre (NPC)</p><p>SFDA Call Center: 19999</p><p>E-mail: npc.drug@sfda.gov.sa</p><p>Website: https://ade.sfda.gov.sa</p><ul><li>&nbsp; &nbsp; Other GCC States</li></ul><p>Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in 04/2021; version number Un1.0.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">سينجرو عبارة عن مركب صناعي مشتق من السوماتوستاتين. يوجد السوماتوستاتين عادةً في جسم الإنسان، حيث يثبط إفراز هرمونات محددة مثل هرمون النمو. تتفوق مزايا سينجرو على هرمون السوماتوستاتين، حيث إنه أقوى من حيث المفعول وتدوم تأثيراته لفترة أطول.</p><p dir="RTL"><strong>يُستخدم سينجرو</strong></p><ul dir="rtl"><li>لعلاج ضخامة الأطراف.</li></ul><p dir="RTL">ضخامة الأطراف هي حالة يفرز فيها الجسم الكثير من هرمون النمو. وهرمون النمو هو المسئول عادةً عن التحكم في نمو الأنسجة والأعضاء والعظام. وتؤدي كثرة إفراز هرمون النمو إلى زيادة حجم العظام والأنسجة، خاصة في اليدين والقدمين. يقلل سينجرو بشكل ملحوظ من أعراض ضخامة الأطراف، التي تشمل الصداع، التعرق المفرط، تنميل اليدين والقدمين، التعب، وألم المفاصل. يحدث فرط إفراز هرمون النمو في معظم الأحيان بسبب تضخم الغدة النخامية (الورم الغُدي النخامي)؛ وقد يقلل العلاج باستخدام سينجرو من حجم الورم الغُدي.</p><p dir="RTL">يُستخدم سينجرو لعلاج الأشخاص المصابين بضخامة النهايات:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; عندما تكون أنواع العلاج الأخرى لضخامة الأطراف (الجراحة أو المعالجة الإشعاعية) غير مناسبة أو غير ناجحة؛</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; بعد المعالجة الإشعاعية، خلال الفترة المؤقتة إلى أن يصبح العلاج الإشعاعي فعّالاً بالكامل.</p><ul dir="rtl"><li>لتخفيف الأعراض المصاحبة لفرط إفراز بعض الهرمونات المحددة والمواد الأخرى ذات الصلة عن طريق المعدة أو الأمعاء أو البنكرياس.</li></ul><p dir="RTL">يمكن أن يحدث فرط إفراز بعض الهرمونات المحددة وغيرها من المواد الطبيعية ذات الصلة بسبب بعض الحالات النادرة التي تحدث في المعدة أو الأمعاء أو البنكرياس. يؤدي هذا إلى خلل في التوازن الهرموني الطبيعي للجسم وينتج عنه مجموعة متنوعة من الأعراض، مثل تورّد، إسهال، انخفاض ضغط الدم، طفح جلدي، وفقدان الوزن. ويساعد العلاج بسينجرو على السيطرة على هذه الأعراض.</p><ul dir="rtl"><li>لعلاج الأورام العصبية الصمَّاوية التي تصيب الأمعاء (مثل الزائدة أو الأمعاء الدقيقة أو القولون).</li></ul><p dir="RTL">الأورام العصبية الصمَّاوية هي أورام نادرة يمكن أن تصيب أجزاءً مختلفة من الجسم.</p><p dir="RTL">يستخدم سينجرو أيضاً للتحكم في نمو هذه الأورام، عندما تصيب الأمعاء (مثل الزائدة أو الأمعاء الدقيقة أو القولون).</p><ul dir="rtl"><li>لعلاج أورام الغدة النخامية التي تفرز الكثير من الهرمون المحفز للغدة الدرقية.</li></ul><p dir="RTL">يؤدي فرط إفراز الهرمون المحفز للغدة الدرقية إلى حدوث فرط نشاط الغدة الدرقية. يُستخدم سينجرو لعلاج الأشخاص المصابين بأورام الغدة النخامية التي تفرز الكثير من الهرمون المحفز للغدة الدرقية.</p><p dir="RTL">-&nbsp; &nbsp; &nbsp; عندما تكون أنواع العلاج الأخرى (الجراحة أو المعالجة الإشعاعية) غير مناسبة أو غير ناجحة؛</p><p>- &nbsp;&nbsp;&nbsp;&nbsp; بعد المعالجة الإشعاعية، خلال الفترة المؤقتة إلى أن يصبح العلاج الإشعاعي فعّالاً بالكامل.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">اتبع جميع التعليمات التي أوصاك بها طبيبك بعناية. قد تختلف عن المعلومات الواردة في هذه النشرة.</p><p dir="RTL">اقرأ التفسيرات التالية قبل استخدام سينجرو.</p><p dir="RTL"><strong>لا تستخدام سينجرو </strong></p><ul dir="rtl"><li>إذا كنت تعاني من حساسية لأوكتريوتيد أو لأي من المواد الأخرى المستخدمة في تركيبة هذا الدواء (المذكورة في القسم ٦).</li></ul><p dir="RTL"><strong>الاحتياطات والتحذيرات </strong></p><p dir="RTL">تحدث مع طبيبك قبل استخدام سينجرو:</p><ul dir="rtl"><li>إذا كنت تعلم أن لديك حصوات صفراوية في الوقت الحالي، أو كانت لديك في الماضي، أو كنت تعاني من أي مضاعفات مثل الحمى، أو الارتعاش، أو ألم في البطن، أو اصفرار الجلد أو العينين؛ فأخبر طبيبك، حيث قد يؤدي استخدام سينجرو لفترات طويلة إلى تكوين حصوة صفراوية. قد يرغب طبيبك في فحص المرارة بشكل دوري.</li><li>إذا كنت تعلم أنك مصاب بمرض السكري، حيث يمكن أن يؤثر سينجرو على مستويات السكر في الدم. إذا كنت مصاباً بمرض السكري، يجب فحص مستويات السكر لديك بانتظام.</li><li>إذا عانيت سابقاً من نقص فيتامين ب١٢، فقد يرغب طبيبك في فحص مستوى فيتامين ب١٢ بشكل دوري.</li></ul><p dir="RTL"><strong>الاختبار والفحوصات</strong></p><p dir="RTL">إذا تلقيت علاجاً بسينجرو على مدار فترة زمنية طويلة، فقد يرغب طبيبك في فحص وظيفة الغدة الدرقية بشكل دوري.</p><p dir="RTL">سيقوم طبيبك بفحص وظائف الكبد.</p><p dir="RTL"><strong>الأطفال </strong></p><p dir="RTL">هناك تجارب قليلة بخصوص استخدام أوكتريوتيد مع الأطفال.</p><p dir="RTL"><strong>الأدوية الأخرى و</strong><strong>سينجرو</strong></p><p dir="RTL">أخبر طبيبك أو الصيدلي إذا كنت تتناول، تناولت مؤخراً، أو قد تتناول أية أدوية أخرى.</p><p dir="RTL">يمكنك الاستمرار بوجه عام في تناول أدوية أخرى أثناء فترة العلاج باستخدام سينجرو. ومع ذلك، تم الإبلاغ عن تأثر بعض الأدوية، مثل السيميتيدين، والسيكلوسبورين، والبروموكريبتين، والكينيدين، والتيرفينادين بأوكتريوتيد.</p><p dir="RTL">إذا كنت تتناول دواءً للتحكم في ضغط الدم (مثل حاصرات بيتا أو حاصرات قنوات الكالسيوم) أو عاملاً للتحكم في توازن السوائل والكهارل، فقد يحتاج طبيبك إلى تعديل الجرعة.</p><p dir="RTL">إذا كنت مصاباً بداء السكري، فقد يحتاج طبيبك إلى تعديل جرعة الإنسولين.</p><p dir="RTL"><strong>الحمل والرضاعة</strong> <strong>&nbsp;</strong></p><p dir="RTL">استشيري طبيبك قبل تناول هذا الدواء، إذا كنت حاملاً أو مرضعًا، تعتقدين بأنك حاملاً أو تخططين لذلك.</p><p dir="RTL">يجب استخدام سينجرو أثناء الحمل فقط إذا كانت الحاجة له ضرورية.</p><p dir="RTL">يجب على النساء اللاتي في سن الحمل استخدام وسيلة فعّالة لمنع الحمل أثناء العلاج.</p><p dir="RTL">لا تُرضعي طبيعياً أثناء استخدام سينجرو. من غير المعروف إذا ما كان أوكتريوتيد ينتقل إلى حليب الثدي أم لا.</p><p dir="RTL"><strong>القيادة واستخدام الآلات </strong></p><p dir="RTL">ليس لسينجرو أي تأثير أو له تأثير ضئيل على القدرة على القيادة واستخدام الآلات. ومع ذلك، قد تعاني من بعض الآثار الجانبية أثناء استخدام أوكتريوتيد، مثل الصداع والتعب، وهو ما قد يقلل من قدرتك على القيادة واستخدام الآلات بأمان.</p><p dir="RTL"><strong>يحتوي سينجرو على الصوديوم</strong></p><p>يحتوي سينجرو على الصوديوم. يحتوي هذا الدواء على أقل من ١ ملمول صوديوم (٢٣ ملغم) لكل جرعة، وبذلك يمكن اعتباره &rsquo;خالٍ من الصوديوم&lsquo; بشكل أساسي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يجب إعطاء سينجرو دائماً على شكل حقنة في عضلات الأرداف. وفي حالة الإعطاء المتكرر، يجب التبديل بين الردفين الأيسر والأيمن.</p><p dir="RTL"><strong>إذا تناولت سينجرو أكثر من اللازم</strong></p><p dir="RTL">لم يتم الإبلاغ عن أي ردود فعل مهددة للحياة بعد أخذ جرعة زائدة من أوكتريوتيد.</p><p dir="RTL">تشمل أعراض استخدام الجرعة الزائدة: هبات ساخنة، وكثرة التبول، والتعب، والاكتئاب، والقلق، وقلة التركيز.</p><p dir="RTL">إذا كنت تعتقد أنك استخدمت جرعة زائدة وظهرت عليك بعض هذه الأعراض، فأخبر طبيبك على الفور.</p><p dir="RTL"><strong>إذا نسيت استخدام سينجرو</strong></p><p dir="RTL">إذا نسيت أخذ الحقنة، فيُنصح بأخذها فور تذكرها، ثم تابع كالمعتاد. لن يحدث أي ضرر إذا تأخرت الجرعة بضعة أيام، ولكن يمكن أن تعاني مجدداً من الأعراض مؤقتاً حتى تسير مجدداً على جدول مواعيد الجرعات المحدد.</p><p dir="RTL"><strong>إذا توقفت عن استخدام سينجرو</strong></p><p dir="RTL">إذا قطعت علاجك بسينجرو فقد تظهر الأعراض مجدداً. لذا، لا تتوقف عن استخدام سينجرو إلا إذا أخبرك الطبيب بذلك.</p><p>إذا كان لديك أي أسئلة إضافية حول استخدام هذا الدواء، اسأل الطبيب، الصيدلي، أو الممرض.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية، قد يسبب هذا الدواء آثاراً جانبية إلا أنه ليس بالضرورة أن تحدث لدى جميع مستخدمي هذا الدواء.</p><p dir="RTL"><strong><em>بعض الآثار الجانبية قد تكون خطيرة. أخبر طبيبك فوراً إذا شعرت بأي مما يلي: </em></strong></p><p dir="RTL"><strong>شائعة جداً (قد تؤثر على أكثر من شخص من بين كل ١٠ أشخاص):</strong> <strong>&nbsp;</strong></p><ul dir="rtl"><li>حصوات صفراوية، تسبب ألماً مفاجئاً في الظهر.</li><li>زيادة نسبة السكر في الدم.</li></ul><p dir="RTL"><strong>شائعة</strong> <strong>(قد تؤثر على ما يصل إلى شخص واحد من بين كل ١٠ أشخاص):</strong></p><ul dir="rtl"><li>انخفاض نشاط الغدة الدرقية (قصور الدرقية) مسببًا تغيرات في معدل نبضات القلب، الشهية أو الوزن؛ التعب، الشعور بالبرودة، أو تورم الجزء الأمامي من العنق.</li><li>تغيرات في اختبارات وظائف الغدة الدرقية.</li><li>التهاب في المرارة (التهاب المرارة)؛ وقد تشمل الأعراض ألماً بالجزء العلوي الأيمن من البطن، وحمى، وغثياناً، واصفرار الجلد والعينين (اليرقان).</li><li>انخفاض نسبة السكر في الدم.</li><li>ضعف تَحمُّل الجلوكوز</li><li>بطء نبضات القلب</li></ul><p dir="RTL"><strong>غير شائعة (قد تؤثر على ما يصل إلى شخص واحد من بين كل ١٠٠ شخص): </strong></p><ul dir="rtl"><li>العطش، انخفاض إخراج البول، البول الداكن، احمرار الجلد وجفافه.</li><li>سرعة نبضات القلب.</li></ul><p dir="RTL"><strong><em>آثار جانبية خطيرة أخرى</em></strong></p><ul dir="rtl"><li>ردود فعل فرط الحساسية (تحسسية)، بما في ذلك الطفح الجلدي.</li><li>نوع من رد الفعل التحسسي (فرط الحساسية) يمكن أن يسبب صعوبة في البلع أو التنفس، تورماً وشعوراً بالوخز، وربما يصاحبه انخفاض ضغط الدم مع دوخة أو فقدان الوعي.</li><li>التهاب غدة البنكرياس (التهاب البنكرياس)؛ وقد تشمل الأعراض ألماً مفاجئاً في الجزء العلوي من البطن، غثيان، تقيؤ، إسهال.</li><li>التهاب الكبد؛ وقد تشمل الأعراض اصفرار الجلد والعينين (اليرقان)، غثيان، تقيؤ، فقدان الشهية، شعوراً عاماً بالإعياء، حكة، بول فاتح اللون.</li><li>عدم انتظام نبضات القلب.</li><li>انخفاض مستوى الصفائح الدموية في الدم؛ قد يؤدي هذا إلى زيادة النزف أو التكدم.</li></ul><p dir="RTL">أخبر طبيبك على الفور إذا لاحظت أياً من الآثار الجانبية المذكورة أعلاه.</p><p dir="RTL"><strong><em>الأعراض الجانبية الأخرى:</em></strong></p><p dir="RTL">أخبر طبيبك، الصيدلي، أو الممرض إذا لاحظت أياً من الآثار الجانبية المذكورة أدناه. عادةً ما تكون خفيفة وتميل إلى الاختفاء مع تقدم العلاج.</p><p dir="RTL"><strong>شائعة جداً</strong> <strong>(قد تؤثر على أكثر من شخص من بين كل ١٠ أشخاص):</strong></p><ul dir="rtl"><li>الإسهال.</li><li>ألم في البطن.</li><li>الغثيان.</li><li>الإمساك.</li><li>انتفاخ البطن (الريح).</li><li>الصداع.</li><li>ألم موضعي في موضع الحقن.</li></ul><p dir="RTL"><strong>شائعة (قد تؤثر على ما يصل إلى شخص واحد من بين كل ١٠ شخص):</strong></p><ul dir="rtl"><li>اضطراب في المعدة بعد الأكل (عسر الهضم).</li><li>القيء.</li><li>الشعور بامتلاء المعدة.</li><li>براز دهني.</li><li>براز رخو.</li><li>تغير لون البراز.</li><li>الدوخة.</li><li>فقدان الشهية.</li><li>تغيير في اختبارات وظائف الكبد.</li><li>تساقط الشعر.</li><li>ضيق النفس.</li><li>ضعف.</li></ul><p dir="RTL">يُرجى إخبار الطبيب، الصيدلي أو الممرض في حال ظهور أية آثار جانبية.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">احفظ هذا الدواء بعيداً عن مرأى ومتناول الأطفال.</p><p dir="RTL">يحفظ داخل الثلاجة (٢-٨˚ مئوية). لا يحفظ مجمداً.</p><p dir="RTL">يحفظ داخل العبوة الأصلية للحماية من الضوء.</p><p dir="RTL">يمكن حفظ سينجرو عند درجة حرارة أقل من ٢٥˚ مئوية في يوم الحقن.</p><p dir="RTL">استخدمه فوراً بعد الحلّ.</p><p dir="RTL">لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية المذكور على العبوة الخارجية بعد عبارة &quot;EXP&quot;.&nbsp; يشير تاريخ الانتهاء إلى اليوم الأخير من ذلك الشهر.</p><p dir="RTL">لا تستخدم هذا الدواء إذا لاحظت وجود جزيئات أو تغيراً في اللون.</p><p dir="RTL">لا تتخلص من أي أدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. هذه الإجراءات ستساعد في الحفاظ على سلامة البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعالة هي أسيتات الأوكتريوتيد.</p><p dir="RTL">تحتوي كل زجاجة من سينجرو ١٠ ملغم مسحوق لتشكيل المعلق ممتد الإطلاق قبل الحقن على ١١,٢ ملغم أسيتات الأوكتريوتيد تكافئ ١٠ ملغم أوكتريوتيد.</p><p dir="RTL">تحتوي كل زجاجة من سينجرو ٢٠ ملغم مسحوق لتشكيل المعلق ممتد الإطلاق قبل الحقن على ٢٢,٤ ملغم أسيتات الأوكتريوتيد تكافئ ٢٠ ملغم أوكتريوتيد.</p><p dir="RTL">تحتوي كل زجاجة من سينجرو ٣٠ ملغم مسحوق لتشكيل المعلق ممتد الإطلاق قبل الحقن على ٣٣,٦ ملغم أسيتات الأوكتريوتيد تكافئ ٣٠ ملغم أوكتريوتيد.</p><p dir="RTL">المواد الأخرى المستخدمة في التركيبة التصنيعية هي:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; المسحوق (الزجاجة): متعدد (د ل-لاكتيد-جليكوليد المشترك) ومانيتول.</p><p>-&nbsp; &nbsp; &nbsp;المذيب (الحقنة مسبقة التعبئة): صوديوم الكارميللوز، مانيتول، بولوكسامير وماء معد للحقن.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right">سينجرو ١٠ ملغم، ٢٠ ملغم و٣٠ ملغم مسحوق ومذيب لتشكيل المعلق ممتد الإطلاق قبل الحقن:</p><p dir="RTL" style="text-align:right">المسحوق: هو مسحوق أبيض مائل إلى الأبيض المصفر وخالٍ من الجزيئات الغريبة، في زجاجات شفافة بحجم ٨ مللتر من النوع رقم واحد، مغلقة بسدّادات مطاطية من الكلوروبوتيل مع أغطية من الألومنيوم قابلة للفتح للأعلى بألوان مختلفة (يتم استخدام الأغطية القابلة للفتح للأعلى ذات الألوان الأزرق الغامق، البرتقالي والأحمر الغامق للتراكيز ١٠ ملغم، ٢٠ ملغم و٣٠ ملغم؛ على التوالي).</p><p dir="RTL" style="text-align:right">المذيب: هو محلول مائي صافٍ عديم اللون وخالٍ من الجزيئات الغريبة، في حقن زجاجية شفافة مسبقة التعبئة بحجم ٣ مللتر من النوع رقم واحد بأغطية عند الرأس، مغلقة بسدّادات المكبس من البروموبوتيل رمادية اللون. يكون قضيب المكبس مرفق في نهاية الجزء الخلفي من سدّادة المكبس.</p><p dir="RTL" style="text-align:right">يتم وضع الزجاجة المعبأة ومُحْكَمة الإغلاق في صينية بلاستيكية بجانب كل من الحقنة مسبقة التعبئة، إبرة الحقن الآمنة ومحوّل الزجاجة؛ يتم تعبئتهم جميعاً في عبوة كرتونية.</p><p dir="RTL" style="text-align:right">حجم العبوة: زجاجة واحدة + حقنة واحدة مسبقة التعبئة (٢ مللتر).</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>اسم وعنوان مالك رخصة التسويق ومحرر التشغيلة </strong></p><p dir="RTL">شركة الجزيرة للصناعات الدوائية<br />طريق الخرج<br />صندوق بريد ١٠٦٢٢٩&nbsp;<br />الرياض ١١٦٦٦، المملكة العربية السعودية<br />هاتف: ٨١٠٧٠٢٣ (١١-٩٦٦)&nbsp;+، ٢١٤٢٤٧٢ (١١-٩٦٦) +<br />فاكس: ٢٠٧٨١٧٠ (١١-٩٦٦) +<br />البريد الإلكتروني: SAPV@hikma.com</p><p dir="RTL"><strong>الشركة المصنعة وبترخيص من</strong></p><p dir="RTL">شركة فارماثين الدولية المساهمة العامة</p><p dir="RTL">المجمع الصناعي سابيس،</p><p dir="RTL">محافظة رودوبي، حي رقم ٥،</p><p dir="RTL">رودوبي ٦٩٣٠٠،</p><p>اليونان</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>للإبلاغ عن الآثار الجانبية</strong></p><p dir="RTL">تحدث إلى الطبيب، الصيدلي، أو الممرض إذا عانيت من أية آثار جانبية. وذلك يشمل أي آثار جانبية لم يتم ذكرها في هذه النشرة. كما أنه يمكنك الإبلاغ عن هذه الآثار مباشرةً (انظر التفاصيل المذكورة أدناه). من خلال الإبلاغ عن الآثار الجانبية، يمكنك المساعدة بتوفير معلومات مهمة عن سلامة الدواء.</p><ul dir="rtl"><li>&nbsp; &nbsp; المملكة العربية السعودية</li></ul><p dir="RTL">المركز الوطني للتيقظ الدوائي</p><p dir="RTL">مركز الاتصال الموحد: 19999</p><p dir="RTL">البريد الإلكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">الموقع الإلكتروني: &nbsp;https://ade.sfda.gov.sa</p><ul dir="rtl"><li>&nbsp; &nbsp; دول الخليج العربي الأخرى</li></ul><p dir="RTL">الرجاء الاتصال بالجهات الوطنية في كل دولة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت مراجعة هذه النشرة بتاريخ ٢٠٢١/٠٤، رقم النسخة: Un1.0.
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Syngro 10 mg Powder and Solvent for Prolonged-release Suspension for Injection
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each vial contains 11.2 mg octreotide acetate equivalent to 10 mg octreotide.

Excipient with known effect: Sodium. 

For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Powder and solvent for prolonged-release suspension for injection. 

Powder: White to off-white powder free from foreign particles. 
Solvent: Clear, colourless, aqueous solution free from foreign particles.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Treatment of patients with acromegaly in whom surgery is inappropriate or ineffective, or in the interim period until radiotherapy becomes fully effective (see section 4.2).</p><p>Treatment of patients with symptoms associated with functional gastro-entero-pancreatic endocrine tumours e.g. carcinoid tumours with features of the carcinoid syndrome (see section 5.1).</p><p>Treatment of patients with advanced neuroendocrine tumours of the midgut or of unknown primary origin where non-midgut sites of origin have been excluded.</p><p>Treatment of TSH-secreting pituitary adenomas:</p><ul><li>When secretion has not normalised after surgery and/or radiotherapy.</li><li>In patients in whom surgery is inappropriate.</li><li>In irradiated patients, until radiotherapy is effective.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Posology</strong></p><p><u>Acromegaly</u></p><p>It is recommended to start treatment with the administration of 20 mg Syngro at 4-week intervals for 3 months. Patients on treatment with s.c. octreotide can start treatment with Syngro the day after the last dose of s.c. octreotide. Subsequent dosage adjustment should be based on serum growth hormone (GH) and insulin-like growth factor 1/somatomedin C (IGF-1) concentrations and clinical symptoms.</p><p>For patients in whom, within this 3-month period, clinical symptoms and biochemical parameters (GH; IGF-1) are not fully controlled (GH concentrations still above 2.5 microgram/L), the dose may be increased to 30 mg every 4 weeks. If after 3 months, GH, IGF-1, and/or symptoms are not adequately controlled at a dose of 30 mg, the dose may be increased to 40 mg every 4 weeks.</p><p>For patients whose GH concentrations are consistently below 1 microgram/L, whose IGF-1 serum concentrations normalised, and in whom most reversible signs/symptoms of acromegaly have disappeared after 3 months of treatment with 20 mg, 10 mg Syngro may be administered every 4 weeks. However, particularly in this group of patients, it is recommended to closely monitor adequate control of serum GH and IGF-1 concentrations, and clinical signs/symptoms at this low dose of Syngro.</p><p>For patients on a stable dose of Syngro, assessment of GH and IGF-1 should be made every 6 months.</p><p><u>Gastro-entero-pancreatic endocrine tumours</u></p><p><em>Treatment of patients with symptoms associated with functional gastro-entero-pancreatic neuroendocrine tumours</em></p><p>It is recommended to start treatment with the administration of 20 mg Syngro at 4-week intervals. Patients on treatment with s.c. octreotide should continue at the previously effective dosage for 2 weeks after the first injection of Syngro.</p><p>For patients in whom symptoms and biological markers are well controlled after 3 months of treatment, the dose may be reduced to 10 mg Syngro every 4 weeks.</p><p>For patients in whom symptoms are only partially controlled after 3 months of treatment, the dose may be increased to 30 mg Syngro every 4 weeks.</p><p>For days when symptoms associated with gastro-entero-pancreatic tumours may increase during treatment with Syngro, additional administration of s.c. octreotide is recommended at the dose used prior to the Syngro treatment. This may occur mainly in the first 2 months of treatment until therapeutic concentrations of octreotide are reached.</p><p><em>Treatment of patients with advanced neuroendocrine tumours of the midgut or of unknown primary origin where non-midgut sites of origin have been excluded</em></p><p>The recommended dose of Syngro is 30 mg administered every 4 weeks (see section 5.1). Treatment with Syngro for tumour control should be continued in the absence of tumour progression.</p><p><u>Treatment of TSH-secreting adenomas</u></p><p>Treatment with Syngro should be started at a dose of 20 mg at 4-weekly intervals for 3 months before considering dose adjustment. The dose is then adjusted on the basis of the TSH and thyroid hormone response.</p><p><u>Use in patients with impaired renal function</u></p><p>Impaired renal function did not affect the total exposure (AUC) to octreotide when administered s.c. as Syngro. Therefore, no dose adjustment of Syngro is necessary.</p><p><u>Use in patients with impaired hepatic function</u></p><p>In a study with octreotide administered s.c. and i.v. it was shown that the elimination capacity may be reduced in patients with liver cirrhosis, but not in patients with fatty liver disease. In certain cases patients with impaired hepatic function may require dose adjustment.</p><p><u>Use in the elderly</u></p><p>In a study with octreotide administered s.c., no dose adjustment was necessary in subjects &ge; 65 years of age. Therefore, no dose adjustment is necessary in this group of patients with Syngro.</p><p><u>Use in children</u></p><p>There is limited experience with the use of octreotide in children.</p><p><strong>Method of administration</strong></p><p>Syngro may only be administered by deep intramuscular injection. The site of repeat intramuscular injections should be alternated between the left and right gluteal muscle (see section 6.6).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Known hypersensitivity to the active substance or to any of the excipients listed in section 6.1. 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>General</strong></p><p>As GH-secreting pituitary tumours may sometimes expand, causing serious complications (e.g. visual field defects), it is essential that all patients be carefully monitored. If evidence of tumour expansion appears, alternative procedures may be advisable.</p><p>The therapeutic benefits of a reduction in growth hormone (GH) levels and normalisation of insulin-like growth factor 1 (IGF-1) concentration in female acromegalic patients could potentially restore fertility. Female patients of childbearing potential should be advised to use adequate contraception if necessary during treatment with octreotide (see section 4.6).</p><p>Thyroid function should be monitored in patients receiving prolonged treatment with octreotide.</p><p>Hepatic function should be monitored during octreotide therapy.</p><p><strong>Cardiovascular related events</strong></p><p>Common cases of bradycardia have been reported. Dose adjustment of medicinal products such as beta blockers, calcium channel blockers, or agents to control fluid and electrolyte balance, may be necessary (see section 4.5).</p><p><strong>Gallbladder and related events</strong></p><p>Cholelithiasis is a very common event during octreotide treatment and may be associated with cholecystitis and biliary duct dilatation (see section 4.8). Additionally, cases of cholangitis have been reported as a complication of cholelithiasis in patients taking octreotide in the post-marketing setting. Ultrasonic examination of the gallbladder before and at about 6-monthly intervals during Syngro therapy is recommended.</p><p><strong>Glucose metabolism</strong></p><p>Because of its inhibitory action on growth hormone, glucagon, and insulin release, octreotide may affect glucose regulation. Post-prandial glucose tolerance may be impaired. As reported for patients treated with s.c. octreotide, in some instances, the state of persistent hyperglycaemia may be induced as a result of chronic administration. Hypoglycaemia has also been reported.</p><p>In patients with concomitant Type I diabetes mellitus, octreotide is likely to affect glucose regulation, and insulin requirements may be reduced. In non-diabetics and type II diabetics with partially intact insulin reserves, octreotide s.c. administration may result in increases in post-prandial glycaemia. It is therefore recommended to monitor glucose tolerance and antidiabetic treatment.</p><p>In patients with insulinomas, octreotide, because of its greater relative potency in inhibiting the secretion of GH and glucagon than that of insulin, and because of the shorter duration of its inhibitory action on insulin, may increase the depth and prolong the duration of hypoglycaemia. These patients should be closely monitored.</p><p><strong>Nutrition</strong></p><p>Octreotide may alter absorption of dietary fats in some patients.</p><p>Depressed vitamin B12 levels and abnormal Schilling&#39;s tests have been observed in some patients receiving octreotide therapy. Monitoring of vitamin B12 levels is recommended during therapy with octreotide in patients who have a history of vitamin B12 deprivation.</p><p><strong>Syngro contains sodium</strong></p><p>Syngro contains sodium. This medicine contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially &lsquo;sodium-free&rsquo;.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Dose adjustment of medicinal products such as beta blockers, calcium channel blockers, or agents to control fluid and electrolyte balance may be necessary when Syngro is administered concomitantly (see section 4.4).</p><p>Dose adjustments of insulin and antidiabetic medicinal products may be required when Syngro is administered concomitantly (see section 4.4).</p><p>Octreotide has been found to reduce the intestinal absorption of ciclosporin and to delay that of cimetidine.</p><p>Concomitant administration of octreotide and bromocriptine increases the bioavailability of bromocriptine.</p><p>Limited published data indicate that somatostatin analogues might decrease the metabolic clearance of compounds known to be metabolised by cytochrome P450 enzymes, which may be due to the suppression of growth hormone. Since it cannot be excluded that octreotide may have this effect, other drugs mainly metabolised by CYP3A4 and which have a low therapeutic index (e.g. quinidine, terfenadine) should therefore be used with caution.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pregnancy</strong></p><p>There is a limited amount of data (less than 300 pregnancy outcomes) from the use of octreotide in pregnant women, and in approximately one third of the cases the pregnancy outcomes are unknown. The majority of reports were received after post-marketing use of octreotide and more than 50% of exposed pregnancies were reported in patients with acromegaly. Most women were exposed to octreotide during the first trimester of pregnancy at doses ranging from 100-1200 micrograms/day of octreotide s.c. or 10-40 mg/month of octreotide. Congenital anomalies were reported in about 4% of pregnancy cases for which the outcome is known. No causal relationship to octreotide is suspected for these cases.</p><p>Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity (see section 5.3).</p><p>As a precautionary measure, it is preferable to avoid the use of Syngro during pregnancy (see section 4.4).</p><p><strong>Breastfeeding</strong></p><p>It is unknown whether octreotide is excreted in human breast milk. Animal studies have shown excretion of octreotide in breast milk. Patients should not breast-feed during Syngro treatment.</p><p><strong>Fertility</strong></p><p>It is not known whether octreotide has an effect on human fertility. Late descent of the testes was found for male offsprings of dams treated during pregnancy and lactation. Octreotide, however, did not impair fertility in male and female rats at doses of up to 1 mg/kg body weight per day (see section 5.3).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Syngro has no or negligible influence on the ability to drive and use machines. Patients should be advised to be cautious when driving or using machines if they experience dizziness, asthenia/fatigue, or headache during treatment with octreotide.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Summary of the safety profile</strong></p><p>The most frequent adverse reactions reported during octreotide therapy include gastrointestinal disorders, nervous system disorders, hepatobiliary disorders, and metabolism and nutritional disorders.</p><p>The most commonly reported adverse reactions in clinical trials with octreotide administration were diarrhoea, abdominal pain, nausea, flatulence, headache, cholelithiasis, hyperglycaemia and constipation. Other commonly reported adverse reactions were dizziness, localised pain, biliary sludge, thyroid dysfunction (e.g., decreased thyroid stimulating hormone [TSH], decreased total T4, and decreased free T4), loose stools, impaired glucose tolerance, vomiting, asthenia, and hypoglycaemia.</p><p><strong>Tabulated list of adverse reactions</strong></p><p>The following adverse drug reactions, listed in Table 1, have been accumulated from clinical studies with octreotide:</p><p>Adverse drug reactions (Table 1) are ranked under heading of frequency, the most frequent first, using the following convention: very common (&ge;1/10); common (&ge;1/100, &lt;1/10); uncommon (&ge;1/1,000, &lt;1/100); rare (&ge;1/10,000, &lt;1/1,000) very rare (&lt;1/10,000), including isolated reports. Within each frequency grouping, adverse reactions are ranked in order of decreasing seriousness.<strong>&nbsp;</strong></p><p><strong>Table 1 Adverse drug reactions reported in clinical studies</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td colspan="2"><p><strong>Gastrointestinal disorders</strong></p></td></tr><tr><td><p>Very common:</p></td><td><p>Diarrhoea, abdominal pain, nausea, constipation, flatulence.</p></td></tr><tr><td><p>Common:</p></td><td><p>Dyspepsia, vomiting, abdominal bloating, steatorrhoea, loose stools, discolouration of faeces.</p></td></tr><tr><td colspan="2"><p><strong>Nervous system disorders</strong></p></td></tr><tr><td><p>Very common:</p></td><td><p>Headache.</p></td></tr><tr><td><p>Common:</p></td><td><p>Dizziness.</p></td></tr><tr><td colspan="2"><p><strong>Endocrine disorders</strong></p></td></tr><tr><td><p>Common:</p></td><td><p>Hypothyroidism, thyroid disorder (e.g., decreased TSH, decreased total T4, and decreased free T4).</p></td></tr><tr><td colspan="2"><p><strong>Hepatobiliary disorders</strong></p></td></tr><tr><td><p>Very common:</p></td><td><p>Cholelithiasis.</p></td></tr><tr><td><p>Common:</p></td><td><p>Cholecystitis, biliary sludge, hyperbilirubinaemia.</p></td></tr><tr><td colspan="2"><p><strong>Metabolism and nutrition disorders</strong></p></td></tr><tr><td><p>Very common:</p></td><td><p>Hyperglycaemia.</p></td></tr><tr><td><p>Common:</p></td><td><p>Hypoglycaemia, impaired glucose tolerance, anorexia.</p></td></tr><tr><td><p>Uncommon:</p></td><td><p>Dehydration.</p></td></tr><tr><td colspan="2"><p><strong>General disorders and administration site conditions</strong></p></td></tr><tr><td><p>Very common:</p></td><td><p>Injection site reactions.</p></td></tr><tr><td><p>Common:</p></td><td><p>Asthenia.</p></td></tr><tr><td colspan="2"><p><strong>Investigations</strong></p></td></tr><tr><td><p>Common:</p></td><td><p>Elevated transaminase levels.</p></td></tr><tr><td colspan="2"><p><strong>Skin and subcutaneous tissue disorders</strong></p></td></tr><tr><td><p>Common:</p></td><td><p>Pruritus, rash, alopecia.</p></td></tr><tr><td colspan="2"><p><strong>Respiratory disorders</strong></p></td></tr><tr><td><p>Common:</p></td><td><p>Dyspnoea.</p></td></tr><tr><td colspan="2"><p><strong>Cardiac disorders</strong></p></td></tr><tr><td><p>Common:</p></td><td><p>Bradycardia.</p></td></tr><tr><td><p>Uncommon:</p></td><td><p>Tachycardia.</p></td></tr></tbody></table><p><strong>Post-marketing</strong></p><p>Spontaneously reported adverse reactions, presented in Table 2, are reported voluntarily and it is not always possible to reliably establish frequency or a causal relationship to drug exposure.</p><p><strong>Table 2 Adverse drug reactions derived from spontaneous reports</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td><p><strong>Blood and lymphatic system disorders</strong></p><p>Thrombocytopenia</p></td></tr><tr><td><p><strong>Immune system disorders</strong></p><p>Anaphylaxis, allergy/hypersensitivity reactions.</p></td></tr><tr><td><p><strong>Skin and subcutaneous tissue disorders</strong></p><p>Urticaria</p></td></tr><tr><td><p><strong>Hepatobiliary disorders</strong></p><p>Acute pancreatitis, acute hepatitis without cholestasis, cholestatic hepatitis, cholestasis, jaundice, cholestatic jaundice.</p></td></tr><tr><td><p><strong>Cardiac disorders</strong></p><p>Arrhythmias.</p></td></tr><tr><td><p><strong>Investigations</strong></p><p>Increased alkaline phosphatase levels, increased gamma glutamyl transferase levels.</p></td></tr></tbody></table><p><strong>Description of selected adverse reactions</strong></p><p><em>Gallbladder and related reactions</em></p><p>Somatostatin analogues have been shown to inhibit gallbladder contractility and decrease bile secretion, which may lead to gallbladder abnormalities or sludge. Development of gallstones has been reported in 15 to 30% of long-term recipients of s.c. octreotide. The incidence in the general population (aged 40 to 60 years) is about 5 to 20%. Long-term exposure to octreotide of patients with acromegaly or gastro-entero-pancreatic tumors suggests that treatment with octreotide does not increase the incidence of gallstone formation, compared with s.c. treatment. If gallstones do occur, they are usually asymptomatic; symptomatic stones should be treated either by dissolution therapy with bile acids or by surgery.</p><p><em>Gastrointestinal disorders</em></p><p>In rare instances, gastrointestinal side effects may resemble acute intestinal obstruction, with progressive abdominal distension, severe epigastric pain, abdominal tenderness and guarding.</p><p>The frequency of gastrointestinal adverse events is known to decrease over time with continued treatment.</p><p><em>Hypersensitivity and anaphylactic reactions</em></p><p>Hypersensitivity and allergic reactions have been reported during post-marketing. When these occur, they mostly affect the skin, rarely the mouth and airways. Isolated cases of anaphylactic shock have been reported.</p><p><em>Injection site reactions</em></p><p>Injection site related reactions including pain, redness, haemorrhage, pruritus, swelling or induration were commonly reported in patients receiving octreotide; however, these events did not require any clinical intervention in the majority of the cases.</p><p><em>Metabolism and nutrition disorders</em></p><p>Although measured faecal fat excretion may increase, there is no evidence to date that long-term treatment with octreotide has led to nutritional deficiency due to malabsorption.</p><p><em>Pancreatic enzymes</em></p><p>In very rare instances, acute pancreatitis has been reported within the first hours or days of octreotide s.c. treatment and resolved on withdrawal of the drug. In addition, cholelithiasis-induced pancreatitis has been reported for patients on long-term octreotide s.c. treatment.</p><p><em>Cardiac disorders</em></p><p>Bradycardia is a common adverse reaction with somatostatin analogues. In both acromegalic and carcinoid syndrome patients, ECG changes were observed such as QT prolongation, axis shifts, early repolarisation, low voltage, R/S transition, early R wave progression, and non-specific ST-T wave changes. The relationship of these events to octreotide acetate is not established because many of these patients have underlying cardiac diseases (see section 4.4).</p><p><em>Thrombocytopenia</em></p><p>Thrombocytopenia has been reported during post-marketing experience, particularly during treatment with octreotide (i.v.) in patients with cirrhosis of the liver, and during treatment with octreotide. This is reversible after discontinuation of treatment.</p><p><strong>Reporting of suspected adverse reactions</strong></p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via:</p><ul><li>Saudi Arabia</li></ul><p>The National Pharmacovigilance Centre (NPC)</p><p>SFDA Call Center: 19999</p><p>E-mail: npc.drug@sfda.gov.sa</p><p>Website: https://ade.sfda.gov.sa</p><ul><li>Other GCC States</li></ul><p>Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>A limited number of accidental overdoses of octreotide have been reported. The doses ranged from 100 mg to 163 mg/month of octreotide. The only adverse event reported was hot flushes.</p><p>Cancer patients receiving doses of octreotide up to 60 mg/month and up to 90 mg/2 weeks have been reported. These doses were in general well tolerated; however, the following adverse events have been reported: frequent urination, fatigue, depression, anxiety, and lack of concentration.</p><p>The management of overdosage is symptomatic.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Somatostatin and analogues, ATC code: H01CB02</p><p>Octreotide is a synthetic octapeptide derivative of naturally occurring somatostatin with similar pharmacological effects, but with a considerably prolonged duration of action. It inhibits pathologically increased secretion of growth hormone (GH) and of peptides and serotonin produced within the GEP endocrine system.</p><p>In animals, octreotide is a more potent inhibitor of GH, glucagon and insulin release than somatostatin is, with greater selectivity for GH and glucagon suppression.</p><p>In healthy subjects octreotide, like somatostatin, has been shown to inhibit:</p><ul><li>Release of GH stimulated by arginine, exercise- and insulin-induced hypoglycaemia,</li><li>Post-prandial release of insulin, glucagon, gastrin, other peptides of the GEP endocrine system, and arginine-stimulated release of insulin and glucagon,</li><li>Thyrotropin-releasing hormone (TRH)-stimulated release of thyroid-stimulating hormone (TSH).</li></ul><p>Unlike somatostatin, octreotide inhibits GH secretion preferentially over insulin and its administration is not followed by rebound hypersecretion of hormones (i.e. GH in patients with acromegaly).</p><p>In patients with acromegaly, Syngro, a galenical formulation of octreotide suitable for repeated administration at intervals of 4 weeks, delivers consistent and therapeutic octreotide serum concentrations thus consistently lowering GH and normalising IGF 1 serum concentrations in the majority of patients. In most patients, octreotide markedly reduces the clinical symptoms of the disease, such as headache, perspiration, paraesthesia, fatigue, osteoarthralgia and carpal tunnel syndrome. In previously untreated acromegaly patients with GH-secreting pituitary adenoma, octreotide treatment resulted in a tumour volume reduction of &gt;20% in a significant proportion (50%) of patients.</p><p>In individual patients with GH-secreting pituitary adenoma, octreotide was reported to lead to shrinkage of the tumour (prior to surgery). However, surgery should not be delayed.</p><p>For patients with functional tumours of the gastro-entero-pancreatic endocrine system, treatment with Syngro provides continuous control of symptoms related to the underlying disease. The effect of octreotide in different types of gastro-entero-pancreatic tumours are as follows:</p><p><strong>Carcinoid tumours</strong></p><p>Administration of octreotide may result in improvement of symptoms, particularly of flushing and diarrhoea. In many cases, this is accompanied by a fall in plasma serotonin and reduced urinary excretion of 5 hydroxyindole acetic acid.</p><p><strong>VIPomas</strong></p><p>The biochemical characteristic of these tumours is overproduction of vasoactive intestinal peptide (VIP). In most cases, administration of octreotide results in alleviation of the severe secretory diarrhoea typical of the condition, with consequent improvement in quality of life. This is accompanied by an improvement in associated electrolyte abnormalities, e.g. hypokalaemia, enabling enteral and parenteral fluid and electrolyte supplementation to be withdrawn. In some patients, computed tomography scanning suggests a slowing or arrest of progression of the tumour, or even tumour shrinkage, particularly of hepatic metastases. Clinical improvement is usually accompanied by a reduction in plasma VIP levels, which may fall into the normal reference range.</p><p><strong>Glucagonomas</strong></p><p>Administration of octreotide results in most cases in substantial improvement of the necrolytic migratory rash which is characteristic of the condition. The effect of octreotide on the state of mild diabetes mellitus which frequently occurs is not marked and, in general, does not result in a reduction of requirements for insulin or oral hypoglycaemic agents. Octreotide produces improvement of diarrhoea, and hence weight gain, in those patients affected. Although administration of octreotide often leads to an immediate reduction in plasma glucagon levels, this decrease is generally not maintained over a prolonged period of administration, despite continued symptomatic improvement.</p><p><strong>Gastrinomas/Zollinger-Ellison syndrome</strong></p><p>Therapy with proton pump inhibitors or H2 receptor blocking agents generally controls gastric acid hypersecretion. However, diarrhoea, which is also a prominent symptom, may not be adequately alleviated by proton pump inhibitors or H2 receptor blocking agents.&nbsp; Syngro can help to further reduce gastric acid hypersecretion and improve symptoms, including diarrhoea, as it provides suppression of elevated gastrin levels, in some patients.</p><p><strong>Insulinomas</strong></p><p>Administration of octreotide produces a fall in circulating immunoreactive insulin. In patients with operable tumours, octreotide may help to restore and maintain normoglycemia pre-operatively. In patients with inoperative benign or malignant tumours, glycaemic control may be improved even without concomitant sustained reduction in circulating insulin levels.</p><p><strong>Advanced neuroendocrine tumours of the midgut or of unknown primary origin where non-midgut sites of origin have been excluded</strong></p><p>A Phase III, randomised, double-blind, placebo-controlled study (PROMID) demonstrated that octreotide inhibits tumour growth in patients with advanced neuroendocrine tumours of the midgut. 85 patients were randomised to receive octreotide 30 mg every 4 weeks (n=42) or placebo (n=43) for 18 months, or until tumour progression or death.</p><p>Main inclusion criteria were: treatment na&iuml;ve; histologically confirmed; locally inoperable or metastatic well-differentiated; functionally active or inactive neuroendocrine tumours/carcinomas; with primary tumour located in the midgut or unknown origin believed to be of midgut origin if a primary within the pancreas, chest, or elsewhere was excluded.</p><p>The primary endpoint was time to tumour progression or tumour-related death (TTP).</p><p>In the intent-to-treat analysis population (ITT) (all randomised patients), 26 and 41 progressions or tumour-related deaths were seen in the octreotide and placebo groups, respectively (HR = 0.32; 95% CI, 0.19 to 0.55; p-value =.000015).</p><p>In the conservative ITT (cITT) analysis population in which 3 patients were censored at randomization, 26 and 40 progressions or tumour-related deaths were observed in the octreotide and placebo groups, respectively (HR=0.34; 95% CI, 0.20 to 0.59; p-value =.000072; Fig 1). Median time to tumour progression was 14.3 months (95% CI, 11.0 to 28.8 months) in the octreotide group and 6.0 months (95% CI, 3.7 to 9.4 months) in the placebo group.</p><p>In the per-protocol analysis population (PP) in which additional patients were censored at end study therapy, tumour progression or tumour-related death was observed in 19 and 38 octreotide and placebo recipients, respectively (HR = 0.24; 95% CI, 0.13 to 0.45; p-value =.0000036).</p><p><strong>Figure 1 Kaplan-Meier estimates of TTP comparing octreotide with placebo (conservative ITT population)</strong><br /><br /><img alt="" width="590" height="363" src="data:image/png;base64,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" /></p><p><strong>Table 3 TTP results by analysis populations</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td rowspan="2">&nbsp;</td><td colspan="2"><p>TTP Events</p></td><td colspan="2"><p>Median TTP months [95% C.I.]</p></td><td rowspan="2"><p>HR [95% C.I.]</p><p>p-value *</p></td></tr><tr><td><p>Octreotide</p></td><td><p>Placebo</p></td><td><p>Octreotide</p></td><td><p>Placebo</p></td></tr><tr><td><p>ITT</p></td><td><p>26</p></td><td><p>41</p></td><td><p>NR</p></td><td><p>NR</p></td><td><p>0.32</p><p>[95% CI, 0.19 to 0.55] P=0.000015</p></td></tr><tr><td><p>cITT</p></td><td><p>26</p></td><td><p>40</p></td><td><p>14.3</p><p>[95% CI, 11.0 to 28.8]</p></td><td><p>6.0</p><p>[95% CI, 3.7 to 9.4]</p></td><td><p>0.34</p><p>[95% CI, 0.20 to 0.59] P=0.000072</p></td></tr><tr><td><p>PP</p></td><td><p>19</p></td><td><p>38</p></td><td><p>NR</p></td><td><p>NR</p></td><td><p>0.24</p><p>[95% CI, 0.13 to 0.45] P=0.0000036</p></td></tr><tr><td colspan="6"><p>NR=not reported; HR=hazard ratio; TTP=time to tumour progression; ITT=intention to treat; cITT=conservative ITT; PP=per protocol</p><p>*Logrank test stratified by functional activity</p></td></tr></tbody></table><p>Treatment effect was similar in patients with functionally active (HR = 0.23; 95% CI, 0.09 to 0.57) and inactive tumours (HR = 0.25; 95% CI, 0.10 to 0.59).</p><p>After 6 months of treatment, stable disease was observed in 67% of patients in the octreotide group and 37% of patients in the placebo group.</p><p>Based on the significant clinical benefit of octreotide observed in this pre-planned interim analysis the recruitment was stopped.</p><p>The safety of octreotide in this trial was consistent with its established safety profile.</p><p><strong>Treatment of TSH-secreting pituitary adenomas</strong></p><p>Octreotide, one i.m. injection every 4 weeks, has been shown to suppress elevated thyroid hormones, to normalise TSH and to improve the clinical signs and symptoms of hyperthyroidism in patients with TSH-secreting adenomas. Treatment effect of octreotide reached statistical significance as compared to baseline after 28 days and treatment benefit continued for up to 6 months.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>After single i.m. injections of Syngro, the serum octreotide concentration reaches a transient initial peak within 1 hour after administration, followed by a progressive decrease to a low undetectable octreotide level within 24 hours. After this initial peak on day 1, octreotide remains at sub-therapeutic levels in the majority of the patients for the following 7 days. Thereafter, octreotide concentrations increase again, and reach plateau concentrations around day 14 and remain relatively constant during the following 3 to 4 weeks. The peak level during day 1 is lower than levels during the plateau phase and no more than 0.5% of the total drug release occurs during day 1. After about day 42, the octreotide concentration decreases slowly, concomitant with the terminal degradation phase of the polymer matrix of the dosage form.</p><p>In patients with acromegaly, plateau octreotide concentrations after single doses of 10 mg, 20 mg and 30 mg octreotide amount to 358 ng/L, 926 ng/L, and 1,710 ng/L, respectively. Steady-state octreotide serum concentrations, reached after 3 injections at 4 week intervals, are higher by a factor of approximately 1.6 to 1.8 and amount to 1,557 ng/L and 2,384 ng/L after multiple injections of 20 mg and 30 mg octreotide, respectively.</p><p>In patients with carcinoid tumours, the mean (and median) steady-state serum concentrations of octreotide after multiple injections of 10 mg, 20 mg and 30 mg of octreotide given at 4 week intervals also increased linearly with dose and were 1,231 (894) ng/L, 2,620 (2,270) ng/L and 3,928 (3,010) ng/L, respectively.</p><p>No accumulation of octreotide beyond that expected from overlapping release profiles occurred over a duration of up to 28 monthly injections of octreotide.</p><p>The pharmacokinetic profile of octreotide after injection of Syngro reflects the release profile from the polymer matrix and its biodegradation. Once released into the systemic circulation, octreotide distributes according to its known pharmacokinetic properties, as described for s.c. administration. The volume of distribution of octreotide at steady-state is 0.27 L/kg and the total body clearance is 160 mL/min. Plasma protein binding amounts to 65% and essentially no drug is bound to blood cells.</p><p>Pharmacokinetic data with limited blood sampling in pediatric patients with hypothalamic obesity, aged 7&ndash;17 years, receiving octreotide 40 mg once monthly, showed mean octreotide trough plasma concentrations of 1,395 ng/L after the first injection and of 2,973 ng/L at steady state. A high inter-subject variability is observed.</p><p>Steady-state trough octreotide concentrations were not correlated with age and BMI, but moderately correlated with body weight (52.3&ndash;133 kg) and was significantly different between male and female patients, i.e. about 17% higher for female patients.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Acute and repeated dose toxicology, genotoxicity, carcinogenicity and reproductive toxicology studies in animals revealed no specific safety concerns for humans.</p><p>Reproduction studies in animals revealed no evidence of teratogenic, embryo/foetal or other reproduction effects due to octreotide at parental doses of up to 1 mg/kg/day. Some retardation of the physiological growth was noted in the offspring of rats which was transient and attributable to GH inhibition brought about by excessive pharmacodynamic activity (see section 4.6).</p><p>No specific studies were conducted in juvenile rats. In the pre- and post-natal developmental studies, reduced growth and maturation was observed in the F1 offspring of dams given octreotide during the entire pregnancy and lactation period. Delayed descent of the testes was observed for male F1 offsprings, but fertility of the affected F1 male pups remained normal. Thus, the above mentioned observations were transient and considered to be the consequence of GH inhibition.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In powder (vial):</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; Poly (DL-lactide-co-glycolide)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; Mannitol.</p><p>In solvent (pre-filled syringe):</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; Carmellose sodium</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; Mannitol</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; Poloxamer</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; Water for injection.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                36 months. 

After reconstitution, use immediately.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store in a refrigerator (2-8&deg;C). Do not freeze.</p><p>Store in the original package in order to protect from light.</p><p>Syngro may be stored below 25&deg;C on the day of injection.</p><p>For storage conditions after reconstitution of the medicinal product, see section 6.3.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Vials: 8 ml type I, clear glass vials, stoppered with chlorobutyl rubber stoppers and sealed with aluminum dark blue flip-off caps.</p><p>Pre-filled syringes: 3 ml type I, clear glass pre-filled syringes with tip caps stoppered with a grey colour, bromobutyl plunger stoppers. A plunger rod is attached at the back end of the plunger stopper.</p><p>The filled and sealed vial is placed in a plastic tray along with the pre-filled syringe, safety injection needle and vial adapter; all are packaged in cardboard box.</p><p>Pack size: 1 Vial + 1 Pre-filled syringe (2 ml).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p><p><strong>Instructions for preparation and intramuscular injection for Syngro</strong></p><p>For deep intramuscular injection only.</p><p><em>Included in the injection kit:</em><br /><img alt="" width="320" height="183" src="data:image/png;base64,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" /></p><p>a.&nbsp; One vial containing Syngro powder</p><p>b.&nbsp; One prefilled syringe containing the vehicle solution for reconstitution</p><p>c.&nbsp; One vial adapter for drug product reconstitution</p><p>d.&nbsp; One safety injection needle.</p><p>Follow the instructions below carefully to ensure proper reconstitution of Syngro before deep intramuscular injection.</p><p>There are 3 critical actions in the reconstitution of Syngro. Not following them could result in failure to deliver the drug appropriately.</p><ul><li>The injection kit must reach room temperature. Remove the injection kit from the fridge and let the kit stand at room temperature for a minimum of 30 minutes before reconstitution, but do not exceed 24 hours.</li><li>After adding the diluent solution, ensure that the powder is fully saturated by letting the vial stand for 5 minutes.</li><li>After saturation, shake the vial moderately in a horizontal direction for a minimum of 30 seconds until a uniform suspension is formed. The Syngro suspension must only be prepared immediately before administration.</li></ul><p>Syngro should only be administered by a trained healthcare professional.</p><p><em>Step 1</em></p><ul><li>Remove the Syngro injection kit from refrigerated storage.&nbsp;</li></ul><p>ATTENTION: It is essential to start the reconstitution process only after the injection kit reaches room temperature. Let the kit stand at room temperature for a minimum of 30 minutes before reconstitution, but do not exceed 24 hours.</p><p>Note: The injection kit can be re-refrigerated if needed.<br /><img alt="" width="135" height="115" src="data:image/png;base64,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" /><br />&nbsp;</p><p><em>Step 2</em></p><ul><li>Remove the plastic cap from the vial and clean the rubber stopper of the vial with an alcohol wipe.</li><li>Peel the blister film and remove the vial adapter from its packaging, by holding between the white luer cap and the skirt. DO NOT touch the tip of the access device at any place.</li><li>Place the vial on a flat surface. Position the vial adapter on top of the vial and push it fully down so that it snaps in place, confirmed by an audible &ldquo;click&ldquo;.</li><li>Clean the tip of the vial adapter with an alcohol wipe.</li></ul><p><img alt="" width="273" height="230" src="data:image/png;base64,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" /></p><p><em>Step 3</em></p><ul><li>Snap off the smooth white cap from the syringe prefilled with diluent solution and screw the syringe onto the vial adapter.</li><li>Slowly push the plunger all the way down to transfer all the diluent solution in the vial.</li></ul><p><strong><img alt="" width="301" height="133" src="data:image/png;base64,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" /></strong></p><p><em>Step 4</em></p><p>ATTENTION: It is essential to let the vial stand for 5 minutes to ensure that the diluent has fully saturated the powder.</p><p>Note: It is normal if the plunger rod moves up as there might be a slight overpressure in the vial.</p><ul><li>At this stage prepare the patient for injection.</li><li><img alt="" width="147" height="126" src="data:image/png;base64,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" /></li></ul><p><em>Step 5</em></p><ul><li>After the saturation period, make sure that the plunger is pushed all the way down in the syringe.</li></ul><p>ATTENTION: Keep the plunger pressed and shake the vial moderately in a horizontal direction for a minimum of 30 seconds so that the powder is completely suspended (uniform milky suspension). Repeat moderate shaking for another 30 seconds if the powder is not completely suspended.</p><p><img alt="" width="240" height="161" src="data:image/png;base64,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" /></p><p><em>Step 6</em></p><ul><li>Turn syringe and vial upside down, slowly pull the plunger back and draw the entire contents from the vial into the syringe.</li><li>Unscrew the syringe from the vial adapter.</li></ul><p><img alt="" width="161" height="277" src="data:image/png;base64,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" /></p><p><em>Step 7</em></p><ul><li>Prepare the injection site with an alcohol wipe.</li><li>Screw the safety injection needle onto the syringe.</li><li>If immediate administration is delayed, gently re-shake the syringe to ensure a milky uniform suspension.</li><li>Pull the protective cover straight off the needle.</li><li>Gently tap the syringe to remove any visible bubbles and expel them from the syringe.</li><li>Proceed immediately to Step 8 for administration to the patient. Any delay may result in sedimentation.</li></ul><p><img alt="" width="197" height="244" src="data:image/png;base64,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" /></p><p><em>Step 8</em></p><ul><li>Syngro must be given only by deep intramuscular injection, never intravenously.&nbsp;</li><li>Insert the needle fully into the left or right gluteus at a 90&deg; angle to the skin.</li><li>Slowly pull back the plunger to check that no blood vessel has been penetrated (reposition if a blood vessel has been penetrated).</li><li>Depress the plunger with steady pressure until the syringe is empty. Withdraw the needle from the injection site and activate the safety guard (as shown in Step 9).</li></ul><p><img alt="" width="305" height="193" src="data:image/png;base64,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" /></p><p><em>Step 9</em></p><ul><li>Activate the safety guard over the needle in one of the 2 methods shown:</li></ul><p>-&nbsp;&nbsp;&nbsp; Either press the hinged section of the safety guard down onto a hard surface (figure A).</p><p>-&nbsp;&nbsp;&nbsp; Or push the hinge forward with your finger (figure B).</p><ul><li>An audible &ldquo;click&rdquo; confirms the proper activation.</li><li>Note: Record injection site on patient&rsquo;s record and alternate monthly.</li><li>Dispose of syringe immediately (in a sharps container).</li></ul><p><img alt="" width="199" height="214" src="data:image/png;base64,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" /></p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Jazeera Pharmaceutical Industries
Al-Kharj Road 
P.O. BOX 106229
Riyadh 11666, Saudi Arabia
Tel: + (966-11) 8107023, + (966-11) 2142472
Fax: + (966-11) 2078170
e-mail: SAPV@hikma.com
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                26 April 2021
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>